Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Objective: cytotoxic agents are the cornerstone of treatment for patients with advanced intrahepatic cholangiocarcinoma (iCCA), despite heterogeneous benefit. We hypothesised that the pretreatment molecular profiles of diagnostic biopsies can predict patient benefit from chemotherapy and define molecular bases of innate chemoresistance.
Design: we identified a cohort of advanced iCCA patients with comparable baseline characteristics who diverged as extreme outliers on chemotherapy (survival <6 m in rapid progressors, RP; survival >23 m in long survivors, LS). Diagnostic biopsies were characterised by digital pathology, then subjected to whole-transcriptome profiling of bulk and geospatially macrodissected tissue regions. Spatial transcriptomics of tumour-infiltrating myeloid cells was performed using targeted digital spatial profiling (GeoMx). Transcriptome signatures were evaluated in multiple cohorts of resected cancers. Signatures were also characterised using in vitro cell lines, in vivo mouse models and single cell RNA-sequencing data.
Results: pretreatment transcriptome profiles differentiated patients who would become RPs or LSs on chemotherapy. Biologically, this signature originated from altered tumour-myeloid dynamics, implicating tumour-induced immune tolerogenicity with poor response to chemotherapy. The central role of the liver microenviroment was confrmed by the association of the RPLS transcriptome signature with clinical outcome in iCCA but not extrahepatic CCA, and in liver metastasis from colorectal cancer, but not in the matched primary bowel tumours.
Conclusions: the RPLS signature could be a novel metric of chemotherapy outcome in iCCA. Further development and validation of this transcriptomic signature is warranted to develop precision chemotherapy strategies in these settings.
chemotherapy, cholangiocarcinoma, liver
496-508
O'Rourke, Colm J.
b72cd8bd-b1a7-47eb-8ce1-c561a22f9cb8
Salati, Massimiliano
431a6ef0-8892-41b5-b020-e0d9c68e2fea
Rae, Colin
ea655c63-9525-47f1-aa0f-0c41be162239
Carpino, Guido
18d894b6-cbd1-4312-b09f-0f91d7e9b5c0
Leslie, Holly
6e49b2e9-e424-4249-9cf7-8e05c9f4d354
Pea, Antonio
63b2d539-5079-4346-807c-c64a22c69aab
Prete, Maria G.
7fb81fcc-e658-4d12-a9be-86b0079ee72d
Bonetti, Luca R.
3d982a6e-aec2-4d44-9dc1-05511664b8d1
Amato, Francesco
d9a8683c-db84-400c-95ce-9c1e87f34710
Montal, Robert
9756c74a-c7d5-488f-9eaf-4633111f2224
Upstill-Goddard, Rosie
490189fd-d153-417c-96b3-b861c8b20626
Nixon, Colin
1b5ad0cd-ae2d-4b1f-80f6-b5401bb83b0a
Sanchon-Sanchez, Paula
5d2fde68-213f-4b0a-ba0a-ff811b9dcf26
Kunderfranco, Paolo
ddd1cbfe-d133-4808-8653-ed91db21c4cb
Sia, Daniela
f832e43e-8854-4cf5-b79e-2e99bc571ee6
Gaudio, Eugenio
90a9fd04-0ad0-4719-8da0-ce21ccceedd8
Overi, Diletta
f981a75b-cc1a-47a1-9699-4d1e8cfbd0a9
Cascinu, Stefano
dd75ee6d-d9f8-4ac7-a49a-d57f1a0cc0f6
Hogdall, Dan
38aae19b-99b3-4d86-aeaa-850d0c5d95f0
Pugh, Sian
7a5be0c6-939c-418b-a98c-8d7068c24c48
Domingo, Enric
10314c45-ec5d-443a-92c7-9d61f5e8169a
Primrose, John N.
d85f3b28-24c6-475f-955b-ec457a3f9185
Bridgewater, John
4701eee2-2c28-4675-9695-efb8e7fc7592
Spallanzani, Andrea
9de7084f-46cc-427a-9f11-6c20c6aa5144
Gelsomino, Fabio
5320f69a-1d25-4327-b58d-97f25296fd93
Llovet, Josep M.
d592b83e-9beb-40e4-8e99-909ee83ee64d
Calvisi, Diego F.
1b161c14-9685-47be-ad1b-20dd1acc9d7c
Boulter, Luke
25f16d84-038f-4210-98fa-7a3119c54695
Caputo, Francesco
40c999bb-b053-4c06-887a-1bde69a02aa4
Lleo, Ana
18f78521-c492-4167-87c1-8b3ffdaa221f
Jamieson, Nigel B.
1fec8ab9-dff5-4c74-870d-aafaff881e34
Luppi, Gabriele
3cee9d14-a5e9-4a6c-88c6-6c810dd51532
Dominici, Massimo
3dbecc2a-6515-427b-a8d6-55a586c358ce
Andersen, Jesper B.
7c024a68-34ca-4290-95f1-189737b712ed
Braconi, Chiara
cee2be47-b8fb-4542-971b-5cf59d852580
27 September 2023
O'Rourke, Colm J.
b72cd8bd-b1a7-47eb-8ce1-c561a22f9cb8
Salati, Massimiliano
431a6ef0-8892-41b5-b020-e0d9c68e2fea
Rae, Colin
ea655c63-9525-47f1-aa0f-0c41be162239
Carpino, Guido
18d894b6-cbd1-4312-b09f-0f91d7e9b5c0
Leslie, Holly
6e49b2e9-e424-4249-9cf7-8e05c9f4d354
Pea, Antonio
63b2d539-5079-4346-807c-c64a22c69aab
Prete, Maria G.
7fb81fcc-e658-4d12-a9be-86b0079ee72d
Bonetti, Luca R.
3d982a6e-aec2-4d44-9dc1-05511664b8d1
Amato, Francesco
d9a8683c-db84-400c-95ce-9c1e87f34710
Montal, Robert
9756c74a-c7d5-488f-9eaf-4633111f2224
Upstill-Goddard, Rosie
490189fd-d153-417c-96b3-b861c8b20626
Nixon, Colin
1b5ad0cd-ae2d-4b1f-80f6-b5401bb83b0a
Sanchon-Sanchez, Paula
5d2fde68-213f-4b0a-ba0a-ff811b9dcf26
Kunderfranco, Paolo
ddd1cbfe-d133-4808-8653-ed91db21c4cb
Sia, Daniela
f832e43e-8854-4cf5-b79e-2e99bc571ee6
Gaudio, Eugenio
90a9fd04-0ad0-4719-8da0-ce21ccceedd8
Overi, Diletta
f981a75b-cc1a-47a1-9699-4d1e8cfbd0a9
Cascinu, Stefano
dd75ee6d-d9f8-4ac7-a49a-d57f1a0cc0f6
Hogdall, Dan
38aae19b-99b3-4d86-aeaa-850d0c5d95f0
Pugh, Sian
7a5be0c6-939c-418b-a98c-8d7068c24c48
Domingo, Enric
10314c45-ec5d-443a-92c7-9d61f5e8169a
Primrose, John N.
d85f3b28-24c6-475f-955b-ec457a3f9185
Bridgewater, John
4701eee2-2c28-4675-9695-efb8e7fc7592
Spallanzani, Andrea
9de7084f-46cc-427a-9f11-6c20c6aa5144
Gelsomino, Fabio
5320f69a-1d25-4327-b58d-97f25296fd93
Llovet, Josep M.
d592b83e-9beb-40e4-8e99-909ee83ee64d
Calvisi, Diego F.
1b161c14-9685-47be-ad1b-20dd1acc9d7c
Boulter, Luke
25f16d84-038f-4210-98fa-7a3119c54695
Caputo, Francesco
40c999bb-b053-4c06-887a-1bde69a02aa4
Lleo, Ana
18f78521-c492-4167-87c1-8b3ffdaa221f
Jamieson, Nigel B.
1fec8ab9-dff5-4c74-870d-aafaff881e34
Luppi, Gabriele
3cee9d14-a5e9-4a6c-88c6-6c810dd51532
Dominici, Massimo
3dbecc2a-6515-427b-a8d6-55a586c358ce
Andersen, Jesper B.
7c024a68-34ca-4290-95f1-189737b712ed
Braconi, Chiara
cee2be47-b8fb-4542-971b-5cf59d852580